Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome

被引:176
作者
Le, LQ
Kabarowski, JHS
Weng, ZG
Satterthwaite, AB
Harvill, ET
Jensen, ER
Miller, JF
Witte, ON [1 ]
机构
[1] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA
[3] Aventis Pharmaceut, Cambridge, MA 02139 USA
[4] Univ Texas, SW Med Ctr, Harold C Simmons Arthrit Res Ctr, Dallas, TX 75390 USA
[5] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA
关键词
D O I
10.1016/S1074-7613(01)00145-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mice with a targeted disruption of the gene encoding a lymphoid-expressed orphan G protein-coupled receptor, G2A, demonstrate a normal pattern of T and B lineage differentiation through young adulthood. As G2A-deficient animals age, they develop secondary lymphoid organ enlargement associated with abnormal expansion of both T and B lymphocytes. Older G2A-deficient mice (>1 year) develop a slowly progressive wasting syndrome, characterized by lymphocytic infiltration into various tissues, glomerular immune complex deposition, and anti-nuclear autoantibodies. G2A-deficient T cells are hyperresponsive to TCR stimulation, exhibiting enhanced proliferation and a lower threshold for activation. Our findings demonstrate that G2A plays a critical role in controlling peripheral lymphocyte homeostasis and that its ablation results in the development of a novel, late-onset autoimmune syndrome.
引用
收藏
页码:561 / 571
页数:11
相关论文
共 49 条
[1]   Mechanisms of disease: Molecular mimicry and autoimmunity. [J].
Albert, LJ ;
Inman, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (27) :2068-2074
[2]   Checkpoints in the progression of autoimmune disease: Lessons from diabetes models [J].
Andre, I ;
Gonzalez, A ;
Wang, B ;
Katz, J ;
Benoist, C ;
Mathis, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (06) :2260-2263
[3]   Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b [J].
Bachmaier, K ;
Krawczyk, C ;
Kozieradzki, I ;
Kong, YY ;
Sasaki, T ;
Oliveira-dos-Santos, A ;
Mariathasan, S ;
Bouchard, D ;
Wakeham, A ;
Itie, A ;
Le, J ;
Ohashi, PS ;
Sarosi, I ;
Nishina, H ;
Lipkowitz, S ;
Penninger, JM .
NATURE, 2000, 403 (6766) :211-216
[4]  
Beadling C, 1999, J IMMUNOL, V162, P2677
[5]   Cbl-b regulates the CD28 dependence of T-cell activation [J].
Chiang, YPJ ;
Kole, HK ;
Brown, K ;
Naramura, M ;
Fukuhara, S ;
Hu, RJ ;
Jang, IK ;
Gutkind, JS ;
Shevach, E ;
Gu, H .
NATURE, 2000, 403 (6766) :216-220
[6]   Identification of a putative G protein-coupled receptor induced during activation-induced apoptosis of T cells [J].
Choi, JW ;
Lee, SY ;
Choi, YW .
CELLULAR IMMUNOLOGY, 1996, 168 (01) :78-84
[7]   Integration of T cell receptor-dependent signaling pathways by adapter proteins [J].
Clements, JL ;
Boerth, NJ ;
Lee, JR ;
Koretzky, GA .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :89-108
[8]   Chemokines - Chemokines and cell migration in secondary lymphoid organs [J].
Cyster, JG .
SCIENCE, 1999, 286 (5447) :2098-2102
[9]   THE SAME TYROSINE-BASED INHIBITION MOTIF, IN THE INTRACYTOPLASMIC DOMAIN OF FC-GAMMA-RIIB, REGULATES NEGATIVELY BCR-DEPENDENT, TCR-DEPENDENT, AND FCR-DEPENDENT CELL ACTIVATION [J].
DAERON, M ;
LATOUR, S ;
MALBEC, O ;
ESPINOSA, E ;
PINA, P ;
PASMANS, S ;
FRIDMAN, WH .
IMMUNITY, 1995, 3 (05) :635-646
[10]   Impaired Fas response and autoimmunity in Pten+/- mice [J].
Di Cristofano, A ;
Kotsi, P ;
Peng, YF ;
Cordon-Cardo, C ;
Elkon, KB ;
Pandolfi, PP .
SCIENCE, 1999, 285 (5436) :2122-2125